Crabel Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,286
Closed -$266K 35
2025
Q4
$266K Buy
+1,286
New +$254K 0.2% 45
2025
Q3
Sell
-1,752
Closed -$268K 56
2025
Q2
$268K Buy
+1,752
New +$269K 0.16% 46
2024
Q4
Sell
-3,299
Closed -$535K 41
2024
Q3
$535K Buy
+3,299
New +$526K 0.38% 38
2024
Q2
Sell
-1,717
Closed -$272K 46
2024
Q1
$272K Buy
+1,717
New +$273K 0.24% 54
2023
Q4
Sell
-5,522
Closed -$860K 136
2023
Q3
$860K Buy
+5,522
New +$911K 0.69% 32
2020
Q1
Sell
-5,514
Closed -$804K 83
2019
Q4
$804K Buy
+5,514
New +$748K 0.31% 24
2018
Q4
Sell
-2,243
Closed -$310K 62
2018
Q3
$310K Buy
+2,243
New +$298K 0.14% 51

Other funds holding JNJ

Crabel Capital Management's JNJ Position: Q1 2026 in Review

Crabel Capital Management sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 1,286 shares — an estimated $266K sold.

Crabel Capital Management first reported a position in JNJ in Q3 2018 and held it in 7 quarters. The position peaked at $860K in Q3 2023. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Crabel Capital Management reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
  • Crabel Capital Management sold 1,286 Johnson & Johnson shares in Q1 2026, an estimated $266K.
  • Crabel Capital Management first reported a position in Johnson & Johnson in Q3 2018 and held it in 7 quarters.
  • Crabel Capital Management's Johnson & Johnson position peaked at $860K in Q3 2023.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Crabel Capital Management's 13F filing for Q1 2026, filed 15 May 2026.